Why the study?
Does indapamide retard provide effective and safe treatment for arterial hypertension in elderly patients?
Does indapamide retard provide effective and safe treatment for arterial hypertension in elderly patients?
Indapamide retard is highlighted as a suitable antihypertensive agent for elderly patients due to its organoprotective properties and tolerability.
Answers are grounded in this paper and cite their sources.
Supports indapamide retard consideration in elderly hypertension; leaves open need for randomized confirmation before practice change.
The modern society faces a steady increase in the numbers of elderly people, which is associated with a range of social and medical problems. Age-related aspects of body anatomy and physiology, multiple comorbidity, and cognitive decline restrict the choice of medications in elderly patients. The paper discusses the need for the agreement between the choice of antihypertensive agents in elderly patients and the importance of organoprotection. From the evidence-based medicine standpoint, indapamide retard is considered as the medication which meets all the requirements for arterial hypertension treatment in elderly patients.
No takes yet. Share an insight, caveat, or question.
Чукаева et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: